FIELD: medicine.
SUBSTANCE: invention concerns medicine and pharmacology, namely, pharmaceutical composition applied at treatment of purulent-destructive processes of a skin and mucosas at external and local application, characterised that it contains tylorone, an emulsion of perfluoroorganic bonds, and as, at necessity, a hydrophylic basis at a certain parity of components.
EFFECT: invention provides expansion of a scope of known active substance - tylorone, restoration of tissue immunity and biocenosis of a skin and mucosas at treatment of purulent-destructive processes of a skin, depression of a secondary necrosis of tissues on the amazed sites, microcirculation improvement in the lesion centre, cupping of inflammatory reactions, reduction of an itch maintenance of high therapeutic activity and convenience in use, acceleration and healing improvement.
19 ex, 4 cl
Title | Year | Author | Number |
---|---|---|---|
LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2351322C1 |
PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
PHARMACEUTICAL COMPOSITION FOR LOCAL AND EXTERNAL APPLICATION WHEN TREATING TRAUMATIC AND POST-OPERATION INJURIES OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2369387C2 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
STEPHAGLABRIN-BASED PHARMACEUTICAL COMPOSITION OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF TRAUMATIC AND POST-OPERATION INJURY OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2371172C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
SYGETHINUM-BASED PHARMACEUTICAL COMPOSITION FOR CLIMACTERIC DISORDERS PREVENTION AND TREATMENT FOR EXTERNAL AND LOCAL APPLICATION | 2007 |
|
RU2341255C1 |
ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
Authors
Dates
2009-04-20—Published
2007-08-31—Filed